Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

³­¼ÒÀÇ Àå¾×¼º Á¾¾ç¿¡¼­ÀÇ p27kip1°ú Cyclin D1 ¹ßÇö¿¡ ´ëÇÑ Á¶»ç Expression of p27kip1 and Cyclin D1 in Serous Epithelial Ovarian Tumors

´ëÇѺ´¸®ÇÐȸÁö 2001³â 35±Ç 3È£ p.220 ~ 225
±Ç¼±¿µ, ÀåÀº¼÷, ±Ç°Ç¿µ, ¹Ú°ü±Ô, ±è¼ö°æ,
¼Ò¼Ó »ó¼¼Á¤º¸
±Ç¼±¿µ ( Kwon Sun-Young ) 
°è¸í´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç

ÀåÀº¼÷ ( Chang Eun-Sook ) 
°è¸í´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
±Ç°Ç¿µ ( Kwon Kun-Young ) 
°è¸í´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
¹Ú°ü±Ô ( Park Kwan-Kyu ) 
°è¸í´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
±è¼ö°æ ( Kim Soo-Kyung ) 
°è¸í´ëÇб³ ÀÇ°ú´ëÇÐ ¾à¸®Çб³½Ç

Abstract


Background: p27kip1 is a member of the Cip/Kip family of the cyclin-dependent kinase inhibitors and is a potential tumor suppressor gene. Decreased expression of p27kip1 is associated with high histologic grade and poor prognosis in a variety of human tumors.

Methods: Sixty-six cases of serous epithelial ovarian tumors were investigated by immunohistochemical staining for p27kip1, cyclin D1, and Ki-67. Clinicopathologic parameters (WHO classification, histologic grade and FIGO stage) were compared with the incidence of p27kip1, cyclin D1 and Ki-67 protein expression in ovarian serous tumors.

Results: Reduced expression of p27kip1 was found more freguently in serous cystadenocarcinoma than in serous cystadenoma and borderline malignancy (p<0.05). The decreased expression of p27kip1 was correlated with a high histologic grade and an advanced FIGO stage. Overexpression of cyclin D1 is associated with borderline malignancy and grade I serous cystadenocarcinoma. An inverse relationship was observed between the p27kip1 protein and the Ki-67 labeling index within serous cystadenocarcinoma, but it was not significant.

Conclusions: Reduced expression of p27kip1 protein plays an important role in the biologically aggressive behavior of serous epithelial ovarian tumors and might represent a useful prognostic marker for predicting the recurrence in primary ovarian tumors.

Å°¿öµå

p27;Cyclin D1;Ovarian neoplasms;Epithelial

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS